Skip to main content

Table 1 Clinical strains used in this study and their sensitivity to A. baumannii phage Bϕ-R2096

From: Efficacy of bacteriophage treatment against carbapenem-resistant Acinetobacter baumannii in Galleria mellonella larvae and a mouse model of acute pneumonia

Species and strains

Sensitivityato phage Bϕ-R2096

EOPb

Species and strains

Sensitivity to phage Bϕ-R2096

EOP

Carbapenem-resistant

A. baumannii

YMC13/03/R2096

++

1.0

Carbapenem-susceptible

A. baumannii

YMC13/05/R728

 

YMC13/01/R1400

++

0.9

YMC13/05/R550

 

YMC13/01/R1224

+

0.6

YMC13/01/R588

 

YMC13/01/R1919

+

0.6

YMC13/06/R2026

 

YMC13/01/R187

+

0.5

YMC13/01/R722

 

YMC13/01/R2058

+

0.6

YMC13/06/R1660

 

YMC13/01/R1238

+

0.7

YMC13/04/R3097

 

YMC13/01/R249

++

0.9

YMC13/01/R3428

 

YMC13/01/R280

++

0.9

YMC13/05/R407

 

YMC13/01/R224

++

0.8

YMC13/04/R3148

 

YMC13/01/R656

+

0.6

YMC13/01/R3291

 

YMC13/03/R12096

+

0.7

Colistin-resistant

A. baumannii

YMC13/07/ R3044

+

0.5

YMC13/01/R317

+

0.5

YMC13/08/R2633

 

YMC13/01/R129

+

0.5

YMC13/09/R888

 

YMC13/01/R3197

+

0.6

Carbapenem-resistant

Pseudomonas aeruginosa

YMC13/01/B10214

 

YMC13/04/B720

+

0.6

YMC13/01/ B11605

 

YMC13/02/R291

 

YMC13/03/ B9708

 

YMC13/02/R319

 

Carbapenem-resistant

Escherichia coli

YMC13/01/ B9566

 

YMC13/02/R401

 

YMC13/01/ B10710

 

YMC13/02/R427

 

YMC13/01/ B11097

 
  1. aPhage activity against collected bacteria: ++, clear plaque; +, turbid plaque; −, no plaque
  2. bThe efficiency of plating (EOP) was calculated as the titer (PFU/ml) on the test bacteria strain divided by titer (PFU/ml) on host bacteria strain